Hypertension

The KENPO-app for specific health guidance is feasible and effective in inducing significant weight loss in Japanese adults with obesity and hypertension. Numerous smartphone apps are available for self-monitoring weight loss. Currently, no mobile applications provide specific health guidance (SHG) for preventing metabolic syndrome, type 2 diabetes, and cardiovascular diseases. A randomized controlled pilot study...

Women pregnant with twins or with a previous diagnosis of pre-eclampsia or high blood pressure may benefit less from aspirin than those with other issues such as body mass index greater than 35 or insulin resistance. Pre-eclampsia (PE) affects 2.1–5.6% of pregnancies and is the second leading cause of maternal mortality worldwide. In addition to...

Risk seems to escalate in dose-response manner for frequency of mobile phone use.  Mobile phone use for making or receiving calls was significantly associated with a higher risk for new-onset hypertension, according to a study published online May 4 in the European Heart Journal: Digital Health. Ziliang Ye, from Southern Medical University in Guangzhou, China, and...

Mental health issues affect people across all socioeconomic and racial/ethnic groups. However, minority and low-income groups commonly face mental health issues with little to no access to diagnosis and treatment.  A secondary analysis of a recent randomized controlled trial published in JAMA Psychiatry indicated that over 50% of African American women with low income and uncontrolled hypertension...

MONDAY, Dec. 7, 2020 — High blood pressure affects Black adults in the U.S. more than any other group. But studies exploring its impact on them remain scant, an analysis of clinical trials over the past decade shows. The analysis, published Monday in the Journal of the American Heart Association, found that of the 956...

Peripheral artery disease (PAD) is a progressive atherosclerotic disease in which one or more peripheral arteries, typically in the lower limbs, are partially or completely obstructed, reducing blood perfusion to the limb. Overall, PAD affects approximately 8.5 million Americans, most of them age 65 and older. A recent analysis of Medicare inpatient and outpatient claims...

Source: www.BloodJournal.org Hypertension with ibrutinib more common than previously reported; this study is first to show association between cancer drug-related hypertension and other heart problems (WASHINGTON, October 3, 2019) — Over half of people prescribed the targeted blood cancer-fighting drug ibrutinib developed new or worsened high blood pressure within six months of starting the medication, according...